Asymchem Laboratories, a CDMO serving the global pharmaceutical and biotech industry, agreed to acquire Snapdragon Chemistry, a US-based chemical technology company, for $58m. "Asymchem truly understands that commitment and we look forward to continuing to develop the high-quality solutions we are known for in their integrated service ecosystem," Dr. Matthew Bio, Snapdragon President and CEO.